129 related articles for article (PubMed ID: 8403622)
1. Applications of gonadotropin-releasing hormone analogues in the treatment of premenstrual syndrome.
Mortola JF
Clin Obstet Gynecol; 1993 Sep; 36(3):753-63. PubMed ID: 8403622
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin.
Mortola JF; Girton L; Fischer U
J Clin Endocrinol Metab; 1991 Feb; 72(2):252A-252F. PubMed ID: 1846868
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
[TBL] [Abstract][Full Text] [Related]
4. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome.
Mezrow G; Shoupe D; Spicer D; Lobo R; Leung B; Pike M
Fertil Steril; 1994 Nov; 62(5):932-7. PubMed ID: 7926137
[TBL] [Abstract][Full Text] [Related]
5. Hormonal management of premenstrual syndrome.
Usman SB; Indusekhar R; O'Brien S
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):251-60. PubMed ID: 17761457
[TBL] [Abstract][Full Text] [Related]
6. Premenstrual syndrome. Tailoring treatment to symptoms.
Nader S
Postgrad Med; 1991 Jul; 90(1):173-80. PubMed ID: 1905806
[TBL] [Abstract][Full Text] [Related]
7. Discussion: 'Add-back regimens in patients using a GnRH agonist for premenstrual dysphoric disorder' by Segebladh et al.
Jungheim ES; Kenerson JJ; Foyouzi-Yousefi N; Allsworth JE; Marquard KL
Am J Obstet Gynecol; 2009 Aug; 201(2):e1-5. PubMed ID: 19646561
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis.
Friedman AJ; Lobel SM; Rein MS; Barbieri RL
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1114-9. PubMed ID: 2145765
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic strategies for managing premenstrual syndrome.
Moline ML
Clin Pharm; 1993 Mar; 12(3):181-96. PubMed ID: 8491076
[TBL] [Abstract][Full Text] [Related]
10. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.
Schmidt PJ; Nieman LK; Danaceau MA; Adams LF; Rubinow DR
N Engl J Med; 1998 Jan; 338(4):209-16. PubMed ID: 9435325
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: a pilot study.
Freeman EW; Sondheimer SJ; Rickels K; Albert J
J Clin Psychiatry; 1993 May; 54(5):192-5. PubMed ID: 8509350
[TBL] [Abstract][Full Text] [Related]
12. The need for add-back with gonadotrophin-releasing hormone agonist therapy.
Studd J; Leather AT
Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():1-4. PubMed ID: 8916978
[TBL] [Abstract][Full Text] [Related]
13. "Add-back" therapy for endometriosis in adolescents.
Lubianca JN; Gordon CM; Laufer MR
J Reprod Med; 1998 Mar; 43(3):164-72. PubMed ID: 9564639
[TBL] [Abstract][Full Text] [Related]
14. Gonadotrophin receptor hormone analogues in combination with add-back therapy: an update.
McLaren JS; Morris E; Rymer J
Menopause Int; 2012 Jun; 18(2):68-72. PubMed ID: 22611225
[TBL] [Abstract][Full Text] [Related]
15. A risk-benefit appraisal of drugs used in the management of premenstrual syndrome.
Mortola JF
Drug Saf; 1994 Feb; 10(2):160-9. PubMed ID: 8011181
[TBL] [Abstract][Full Text] [Related]
16. The premenstrual syndrome.
Muse K
Curr Opin Obstet Gynecol; 1991 Dec; 3(6):865-9. PubMed ID: 1818726
[TBL] [Abstract][Full Text] [Related]
17. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen.
Sundström I; Nyberg S; Bixo M; Hammarbäck S; Bäckström T
Acta Obstet Gynecol Scand; 1999 Nov; 78(10):891-9. PubMed ID: 10577620
[TBL] [Abstract][Full Text] [Related]
18. The premenstrual syndrome. Effects of "medical ovariectomy".
Muse KN; Cetel NS; Futterman LA; Yen SC
N Engl J Med; 1984 Nov; 311(21):1345-9. PubMed ID: 6387488
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder.
Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I
Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092
[TBL] [Abstract][Full Text] [Related]
20. Steroidal and nonsteroidal "add-back" therapy: extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patient.
Surrey ES
Fertil Steril; 1995 Oct; 64(4):673-85. PubMed ID: 7672133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
